@inbook{8dc359384da849ec8e1792e011de8f0d,
title = "Miscellaneous antibacterial drugs",
abstract = "Appraisal of available literature published from January 2019 to April 2020 yielded a total of 98 studies, 14 of which pertained to aminoglycosides, 26 to fluoroquinolones, 23 to glycopeptides, 3 to clindamycin, 13 to macrolides, 7 to oxazolidinones, 4 to polymyxins, 5 to trimethoprim/sulfamethoxazole, 2 to daptomycin, 1 to nitrofurantoin, 1 to fosfomycin, and 1 to lefamulin. Our search yielded no pertinent literature for tedizolid and for trimethoprim alone.",
keywords = "Aminoglycosides, Clindamycin, Daptomycin, Fluoroquinolones, Glycopeptides, Lefamulin, Macrolides, Oxazolidinones, Polymyxins, Trimethoprim–sulfamethoxazole, Urinary antibiotics",
author = "Cota, {Jason M.} and Benavides, {Taylor M.}",
note = "Publisher Copyright: {\textcopyright} 2020 Elsevier B.V.",
year = "2020",
month = jan,
doi = "10.1016/bs.seda.2020.09.008",
language = "English",
isbn = "9780128203309",
series = "Side Effects of Drugs Annual",
publisher = "Elsevier B.V.",
pages = "265--278",
editor = "Ray, {Sidhartha D.}",
booktitle = "A Worldwide Yearly Survey of New Data in Adverse Drug Reactions",
}